-
Seminario Web Cure Duchenne: Explicación de la Decisión de la FDA acerca de Elevidys
Watch HERE The post Seminario Web Cure Duchenne: Explicación de la Decisión de la FDA […]
-
Dyne Therapeutics of DYNE-251 in Duchenne
Dyne Therapeutics shares with the community recent efficacy and safety data from the ongoing DELIVER […]
-
ITF THERAPEUTICS| DUVYZAT Update
CureDuchenne Webinar | ITF THERAPEUTICS Patient Community Update: An overview of DUVYZAT Recorded on June […]
-
PPMD 2024: Building community is vital for mental, physical health
Connecting with a supportive community is essential for people affected by muscular dystrophy to maintain both […]
-
PPMD 2024: PTC to seek FDA approval of ataluren for DMD
PTC Therapeutics plans to soon ask the U.S. Food and Drug Administration (FDA) to approve […]
-
PPMD 2024: DMD therapies to boost dystrophin advance in trials
More than half a dozen exon-skipping therapies for Duchenne muscular dystrophy (DMD) — all seeking […]
-
Protected: Duchenne Bone Health Study
This content is password protected. To view it please enter your password below: Password: The […]
